Alps Advisors Inc
- SEC CIK
- 0001376113
- Latest filing
- Jul 29, 2026
PTGX holding history
Protagonist Therapeutics, Inc in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PTGX overviewAll 13F holders of PTGXFull Q2 2026 holdings
- Shares (Q4 2025)
- 0
- Sold out in Q4 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 16
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2025 | 0 | $0 | 0.0% | −29,203−100.0% | Sold out | Holders |
| Q3 2025 | 29,203 | $1.94M | <0.1% | −11,017−27.4% | Reduced | Holders |
| Q2 2025 | 40,220 | $2.22M | <0.1% | −12,754−24.1% | Reduced | Holders |
| Q1 2025 | 52,974 | $2.56M | <0.1% | −2,967−5.3% | Reduced | Holders |
| Q4 2024 | 55,941 | $2.16M | <0.1% | +3,909+7.5% | Added | Holders |
| Q3 2024 | 52,032 | $2.34M | <0.1% | +6,260+13.7% | Added | Holders |
| Q2 2024 | 45,772 | $1.59M | <0.1% | +4,673+11.4% | Added | Holders |
| Q1 2024 | 41,099 | $1.19M | <0.1% | +1,027+2.6% | Added | Holders |
| Q4 2023 | 40,072 | $918.9K | <0.1% | −2,377−5.6% | Reduced | Holders |
| Q3 2023 | 42,449 | $708.0K | <0.1% | +368+0.9% | Added | Holders |
| Q2 2023 | 42,081 | $1.16M | <0.1% | +9,666+29.8% | Added | Holders |
| Q1 2023 | 32,415 | $745.5K | <0.1% | −934−2.8% | Reduced | Holders |
| Q4 2022 | 33,349 | $363.8K | <0.1% | +6,528+24.3% | Added | Holders |
| Q3 2022 | 26,821 | $226.0K | <0.1% | −2,048−7.1% | Reduced | Holders |
| Q2 2022 | 28,869 | $228.0K | <0.1% | −20,891−42.0% | Reduced | Holders |
| Q1 2022 | 49,760 | $1.18M | <0.1% | −5,472−9.9% | Reduced | Holders |
| Q4 2021 | 55,232 | $1.89M | <0.1% | +55,232 | New | Holders |